5th Clinical Trials Nexus 2019

Procurement Direct Ltd is pleased to announce that a fantastic meeting Clinical Trials Nexus will be returning to Boston for its 5th  edition on 16-17 May 2019 in Boston, USA. Procurement Direct Ltd carefully researched each year to ensure that delegates & sponsors are exposed to the highest level of expertise.

Event Schedule
Event Speakers
Day 1 : Timeline of Events
07:45 _08:45 Registration
08:45 - 09:00 Chair Person Welcome
09:00 - 09:30 Keynote 1
09:30 - 10:00 Keynote 2
10:00 - 10:30 Panel Discussion
12:10 - 12:40 Keynote 3
12:40 - 13:10 Keynote 4
13:10-13:40 Keynote 5
13:40 - 14:40 Lunch Break
Day 2 : Timeline of Events
  • Dicerna Pharmaceutical, Senior Clinical Scientist
  • Chief Medical Officer, Sentien Biotechnologies, Inc.
    Assuring greater patient centric trials which can improve trial results by encouraging higher levels of retention and engagement while targeting patients smartly
  • CEO and co-founder, Novapeutics LLC
  • Head of Innovation in Portfolio and Operations, Bayer
    Harnessing new technologies to maximize the relationship between investigator and patient to improve reporting and reduce dropout rates
  • Sr Director Clinical Development, GSK
  • Senior Associate Director, Site Enablement, Boehringer Ingelheim
  • Sr Director, Mersana Therapeutics
  • Takeda Pharmaceuticals, Associate Director of Mechanistic and Investigative Toxicology
  • Vice President, Medical Affairs, Acer Therapeutics Inc
    Exploring new paradigms in clinical trial operations, partnerships and outsourcing to discern what new challenges need to be addressed
  • President & CEO, Neurotez, Inc.
  • Consultant Takeda Digital Accelerator, Takeda Oncology
    A Novel Digital Outreach Strategy for Patient Engagement
  • Senior Director, Otsuka Pharmaceutical Companies (U.S.)
  • CAO and Co-founder, Berg, LLC
  • Founder, Interim CEO, Chief Science Officer, Celigenex, Inc.
    Analyzing clinical trials outsourcing trends: Ways to improve quality & speed of clinical trials & Pre-trial due diligence
  • President & CEO, AVM Biotechnology
  • VP, Head of Ophthalmology, Casebia Therapeutics
  • Head of Clinical Operations, AoBiome
  • Associate Director Business Process and Integration, Shire